research use only
Cat.No.S7870
| Related Targets | PI3K Akt mTOR GSK-3 ATM/ATR DNA-PK AMPK PDPK1 PTEN PP2A |
|---|---|
| Other S6 Kinase Inhibitors | PF-4708671 BI-D1870 LY2584702 LY2584702 Tosylate LJI308 S6K-18 3'-Hydroxypterostilbene L-Norvaline BRD7389 Gingerenone A |
| Molecular Weight | 381.42 | Formula | C22H21F2N3O |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1627710-50-2 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CN1CCN(CC1)C2=CC=C(C=C2)C3=C(C=NC=C3)C4=CC(=C(C(=C4)F)O)F | ||
|
In vitro |
Ethanol : 20 mg/mL
DMSO
: 10 mg/mL
(26.21 mM)
Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
RSK3
(Cell-free assay) 4 nM
RSK2
(Cell-free assay) 5 nM
RSK1
(Cell-free assay) 6 nM
|
|---|---|
| In vitro |
LJH685 modulates YB1 phosphorylation by potently and selectively inhibiting RSK in cells. In MAPK pathway–dependent cancer cell lines, this compound shows antiproliferative effects, and causes cell-cycle regulation and apoptosis induction.
|
| Kinase Assay |
Inhibition of RSK1, RSK2, and RSK3 activity
|
|
Enzymatic activity of RSK isoforms 1, 2, and 3 (PV4049, PV4051, and PV3846) is assessed using recombinant full-length RSK protein. RSK1 (1 nmol/L), RSK2 (0.1 nmol/L), or RSK3 (1 nmol/L) is allowed to phosphorylate 200 nmol/L peptide substrate (biotin-AGAGRSRHSSYPAGT-OH) in the presence of ATP at concentration equal to the Km for ATP for each enzyme (RSK1, 5 μmol/L; RSK2, 20 μmol/L; and RSK3, 10 μmol/L) and appropriate dilutions of this compound.
|
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.